Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial from FDA

About this update from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

Announcement on Holding Subsidiary’s Drug Obtaining Approval for Clinical Trial from FDA The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A